Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00215059 · ClinicalTrials.gov registry record
Measurement of Angiogenic Related Growth Factors in Urine and Blood From Patients With Pulmonary Vein Stenosis
A clinical trial, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- 50
- Enrollment target
NCT00215059 is a clinical trial that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 50 participants.
The verdict
NCT00215059 was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Prospective, single center, descriptive study in 14 infants/children with multivessel pulmonary vein stenosis stratified for patients with or without underlying cardiac disease. Group 1: Patients without additional structural heart disease and multivessel pulmonary vein stenosis. Group 2: Patients with additional structural heart disease and multivessel pulmonary vein stenosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2000-08 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00215059
The ClinicalTrials.gov registry entry for NCT00215059 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00215059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00215059 about?
NCT00215059 is a clinical study titled "Measurement of Angiogenic Related Growth Factors in Urine and Blood From Patients With Pulmonary Vein Stenosis". Prospective, single center, descriptive study in 14 infants/children with multivessel pulmonary vein stenosis stratified for patients with or without underlying cardiac disease. Group 1: Patients without additional structural heart disease and multivessel pulmonary vein stenosis. Group 2: Patients...
What is the current status of trial NCT00215059?
This trial is currently terminated. The enrollment target is 50 participants. The study started on 2000-08. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT00215059?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.